Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Brain Neoplasms 9Squamous Cell Carcinoma of Head and Neck 7Glioblastoma 7Polycythemia Vera 6Gliosarcoma 6Leukemia 5Head and Neck Neoplasms 5Meningioma 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myeloid, Acute 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Neoplasms 3Myelodysplastic Syndromes 3Laryngeal Neoplasms 3Central Nervous System Neoplasms 3Thrombocythemia, Essential 2Stomach Neoplasms 2Salivary Gland Neoplasms 2Pharyngeal Neoplasms 2Paranasal Sinus Neoplasms 2Oropharyngeal Neoplasms 2Myeloproliferative Disorders 2Myelodysplastic-Myeloproliferative Diseases 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Hypopharyngeal Neoplasms 2Glioma 2Congenital Abnormalities 2Carcinoma, Squamous Cell 2Astrocytoma 2

Interventions

Cisplatin 8Radiotherapy 4Pemetrexed 4Cetuximab 4Gemcitabine 3Gefitinib 2Fluorouracil 2Drug Therapy 2Docetaxel 2Carboplatin 2pembrolizumab 1X-Rays 1Vitamin B 12 1Tirapazamine 1Radiotherapy, Intensity-Modulated 1Radiosurgery 1Radiation 1Paclitaxel 1Nivolumab 1Nimorazole 1Narrow Band Imaging 1Metformin 1MLN 8237 1LY2940680 1Ipilimumab 1Hydroxyurea 1Gabapentin 1Folic Acid 1Fibroblast Growth Factor 7 1Chemical Fractionation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Laryngeal Diseases × Hydroxyurea × Clear all
NCT01693718 2024-01-29

A Multicenter Study of Intensive Concomitant Chemoradiotherapy With Filgrastim (GCSF) for Patients With Locoregionally Advanced Head and Neck Cancer

University of Chicago

Phase 2 Completed
44 enrolled
Head & Neck

Laryngeal Diseases, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡